SJM three-lens brief
Evidence-based stock research on SJM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 16.6pp over 30 days. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Underperforming SPY by 16.6pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $118.13 — 23% above current (16 analysts).
- Debt-to-equity of 143.2 — balance-sheet-heavy.
SJM closed at $96.07 (-0.12%) as of 2026-04-25. Market cap: $10.25B. Positives: analyst mean target $118.13 — 23% above current (16 analysts).. Concerns: underperforming SPY by 16.6pp over 30 days.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $2.34B, net income -$724.20M, free cash flow $884.46M.
Why three lenses on SJM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine SJMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/SJM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath SJM brief"></iframe>